FDA guidance on API-excipient co-crystals unnecessary; Amgen
Amgen has called FDA draft guidance on API-excipient co-crystals unnecessary in its written response to the Agency.
Archives for March 5, 2012
EU regulators should copy US FDA over combination product guidelines, says expert
Regulation over combination products must be simplified to get products to market quicker, said Marielle Fournier, director of Voisin Life Sciences Consulting.
Danadams issues wake-up call to Ghanaian government: “Make more drugs locally”
Danadams' CEO Yaw Adu Gyamfi will tomorrow meet with the Ghanaian Government urging them to establish a drugs fund which will see more meds manufacturing in the country.
News from AMRI, West Pharmaceuticals and Sanofi – People on the move
Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from AMRI, West Pharmaceuticals and Sanofi.
BASi starts restructuring to cut costs
Bioanalytical Systems (BASi) will restructure its laboratory operations in a bid to cut costs and maintain an operating profit.
update
Icon wins Roche SaaS deal for image management
Icon will manage all of Roche’s medical images under a new technology partnership announced today.